bioMérieux S.A. (OTCMKTS:BMXMF) Sees Large Increase in Short Interest

bioMérieux S.A. (OTCMKTS:BMXMF) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 154,600 shares, an increase of 43.1% from the February 13th total of 108,000 shares. Based on an average daily volume of 1,300 shares, the days-to-cover ratio is presently 118.9 days. Approximately 0.1% of the shares of the stock are short sold.

bioMérieux Stock Performance

BMXMF opened at $123.74 on Tuesday. The firm’s 50-day simple moving average is $117.82 and its 200-day simple moving average is $113.34. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10. bioMérieux has a twelve month low of $93.50 and a twelve month high of $126.64.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.